November 28, 2018
Ono Pharmaceutical announced on November 27 that it has submitted in Japan a new drug application for anamorelin HCl, a ghrelin receptor agonist, for the improvement of body weight loss and anorexia in patients with cancer cachexia. Cancer cachexia is...read more